Affiliation:
1. Department of Radiodiagnosis, Air Force Central Medical Establishment, New Delhi, India,
Abstract
There is significant increase in number of COVID-19 vaccination recipients around the world to contain the COVID-19 pandemic. However, one of the most common adverse effects of COVID-19 vaccine is unilateral axillary lymphadenopathy. There is variable time for complete resolution of reactive lymphadenopathy. It has, therefore, lead to diagnostic dilemma for oncological imaging for breast cancer in recent times. We describe a case of unilateral axillary lymphadenopathy in a patient following COVID-19 vaccination, which was finally proven to be invasive carcinoma on histopathology.